Ellen D. Teplitz

https://assets.montefioreeinstein.org/profiles/images/2882-teplitz.jpg

First Name

Ellen

Last Name

Teplitz

NPI

1174683742

Faculty ID

2882

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3602

Is Open Scheduling

Off

Beth N. McLellan

https://assets.montefioreeinstein.org/profiles/images/physphoto/McLellan_Beth_MD_LC_420x504.jpg

First Name

Beth

Last Name

McLellan

NPI

1356512412

Faculty ID

14084

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Beth McLellan graduated with honors from Northwestern University and attended medical school at Wayne State University where she graduated with Alpha Omega Alpha honors. She completed an internship in Internal Medicine at Loyola University Health System and her Dermatology residency at Henry Ford Health System in Detroit where she also served as Chief Resident. She currently is a Professor in the Department of Medicine (Dermatology) and has served as Chief of the Division of Dermatology since 2020.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan specializes in complex medical Dermatology and has a special interest in Supportive Oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair, and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis as well as successful use of bacterial decolonization for prevention of radiation dermatitis. She has published numerous articles and textbook chapters related to Supportive Oncodermatology and is regularly invited to speak at Dermatology and Oncology conferences for physicians and patients including the annual meeting of the American Academy of Dermatology, ASCO, and Gilda's Club.</span></p>
<p class="MsoNormal" style="margin-bottom: 0in; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Playing an active role in the Dermatology Residency, Dr. McLellan is the director of resident research and regularly lectures residents and medical students. She has served as a mentor to many residents and students and directs a year-long Oncodermatology research fellowship for medical students taking a year off for research.&nbsp; Interested medical students can learn more about the fellowship here: https://www.einsteinmed.edu/departments/medicine/divisions/dermatology/…;
<div>&nbsp;</div>
<div>&nbsp;</div>
<div>&nbsp;</div>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.

Research Focus

Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis

Elsevier Profile

Selected Publications

<p><a href="https://www.ncbi.nlm.nih.gov/sites/myncbi/1-KCbcoWaApUyh/bibliography/5…;

EMR ID

5777

Biography

<p>Beth N. McLellan, MD, is Chief, Dermatology, Director, Supportive Oncodermatology and Professor, Dermatology at Montefiore Einstein. She specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</p><p>After earning her Doctor of Medicine at Wayne State University, Dr. McLellan completed an internship in internal medicine at Loyola University Health System and her dermatology residency at Henry Ford Health System where she also served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institut Gustave Roussy in Paris, France.</p><p>Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis. Playing an active role in the Montefiore Einstein Dermatology Residency, Dr. McLellan is the Director of Resident Research and regularly lectures residents and medical students at both dermatology and oncology meetings. She has served as a mentor to many residents and students and directs a year long oncodermatology research fellowship for medical students taking a year off for research. Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology and is regularly invited to speak at dermatology and oncology conferences for physicians and patients, including the annual meeting of the American Academy of Dermatology, American Society of Clinical Oncology and Gilda's Club.</p><p>As part of her commitment to treating the whole patient, Dr. McLellan founded the New York Vitiligo Support Group. She has received awards from the Dermatology Foundation.</p>

Is Open Scheduling

On

David H. Ciocon

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/1f99b570-35c5-11ed-8123-8ffce84a9f6a.jpg

First Name

David

Last Name

Ciocon

NPI

1790878866

Faculty ID

12226

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. David Ciocon received his undergraduate degree from Harvard University (cum laude with HIgh Honors in History and Literature) and his M.D. from UMDNJ-New Jersey Medical School, where he was elected to the Alpha Omega Alpha Honor Society. Prior to his residency in dermatology, he completed three years of a combined general and plastic surgery residency training at Brown University, Rhode Island Hospital as well as a one-year clinical research fellowship in psoriasis at Harvard University, Brigham &amp; Women's Hospital. He subsequently completed a dermatology residency at the Albert Einstein College of Medicine, Montefiore Medical Center, where he was Chief Resident and recipient of the Leo M. Davidoff Award for Excellence in Teaching. He then completed a Mohs Micrographic Surgery and Procedural Dermatology fellowship at Skin Laser &amp; Surgery Specialists of New York and New Jersey under the guidance of Dr. David Goldberg in 2009.&nbsp;</p>
<p>Since 2013, Dr. Ciocon has served as the Director of Dermatologic Surgery, Mohs Micrographic Surgery and Procedural Dermatology at the Montefiore Medical Center, Albert Einstein College of Medicine. He has also serves as the Director of Clinical Operations of the Dermatology Division of the Montefiore Medical Center.&nbsp;</p>
<p>Dr. Ciocon is a member of the American Society for Dermatologic Surgery, the American Academy of Dermatology, and the American College of Mohs Surgery. He serves on the Editorial Board of the Journal of Cosmestic and Laser Therapy. He is a preceptor in the American Society of Dermatologic Surgery Preceptor program.</p>
<p>Dr. Ciocon's clinical interests include Mohs Micrographic surgery, facial reconstructive and aesthetic surgery, laser-assisted tumescent liposuction, autologous fat transfer, laser medicine, and minimally invasive cosmetic dermatology. He has written multiple peer-reviewed publications and textbooks with respect to surgical and non-surgical approaches to cutaneous oncology, cutaneous reconstruction, and aesthetic rejuvenation.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Lab Website Link

Selected Publications

<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Soliman YS, Mieczkowska K, Zhu TR, Hossain O, Zhu TH, <strong>Ciocon DH</strong>, Williams RF. Characterizing basal cell carcinoma in Hispanic individuals undergoing Mohs micrographic surgery: a 7-year retrospective review at an academic institution in the Bronx. Br J Dermatol. 2022 Oct;187(4):597-599.</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">&nbsp;</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Williams RF, <strong>Ciocon DH.</strong> Mohs Micrographic Surgery in Skin of Color. J Drugs Dermatol. 2022 May 1;21(5):536-541.</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">&nbsp;</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Dautriche-Svidzinski CN, Manning J, Williams RF<strong>, Ciocon DH</strong>. Treatment algorithm for basal cell carcinoma of the external auditory canal. Dermatol Surg. 2022 Mar 1;48(3):372-373.</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">&nbsp;</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Soliman YS, Mieczkowska K, Zhu TR, Hossain O, &nbsp;Zhu TH, <strong>Ciocon DH</strong>, Williams RF. Keratinocyte carcinoma resected by Mohs micrographic surgery in individuals with skin of color: An observational study. J Am Acad Dermatol. 2023 May;88(5):1183-1185.</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;">&nbsp;</h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Hoffman L, Benesh G, Soliman Y,&nbsp;<strong>Ciocon D</strong>, Williams R<span style="color: #212121; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">. </span>Diversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship. J Drugs Dermatol. 2023 May 1;22(5):471-474.</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">&nbsp;</span></h2>
<h2 class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">Nazarian R, Manning J, <strong>Ciocon DH</strong>. Repair of a nasal tip defect. </span>Dermatol Surg. 2023 Sep 1;49(9):889-891.</h2>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;">&nbsp;</p>

EMR ID

4822

Biography

<p>David Ciocon, MD, is Director, Mohs Micrographic Surgery and Procedural Dermatology and Director, Clinical Operations, Dermatology Division at Montefiore Einstein and Associate Professor, Dermatology at our Albert Einstein College of Medicine. Dr. Ciocon&rsquo;s clinical focus centers on Mohs micrographic surgery, cutaneous oncology, cosmetic dermatologic surgery and lasers.</p><p>After obtaining his Bachelor of Arts from Harvard University in 1994, Dr. Ciocon earned his Doctor of Medicine at Rutgers University in 2002. He completed an internship and residency in general and plastic surgery at Brown University, Rhode Island Hospital in 2005 and became a dermatopharmacology research fellow at Harvard University, Brigham and Women's Hospital until 2006. Following this, Dr. Ciocon completed his dermatology residency at Albert Einstein College of Medicine in 2009, where he was Chief Resident in his final year. He then completed a Mohs micrographic surgery and procedural dermatology fellowship at Skin Laser & Surgery Specialists of New York and New Jersey in 2010.</p><p>Building on his clinical focus, Dr. Ciocon&rsquo;s research is focused on Mohs micrographic surgery, dermatologic oncology, cosmetic dermatologic surgery and lasers. His work has been published in numerous peer-reviewed journals, books, book chapters and abstracts. He has also given many national presentations.</p><p>Dr. Ciocon is board certified by the American Board of Dermatology with a subspecialty certification in Micrographic Dermatologic Surgery. He is a member of several professional organizations, including the American Medical Association, the American Academy of Dermatology and the American Society of Dermatologic Surgery, among others. In 2009, Dr. Ciocon received the Leo M. Davidoff Award for Excellence in Teaching. He has been named "Top Doctor" in both <em>New York Magazine</em> and <em>Westchester Magazine</em>, as well as "Top Doctor, New York City Metro Area" by Castle Connolly for multiple consecutive years.</p>

Is Open Scheduling

Off